Report License

$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off

Order Review

Lung Adenocarcinoma Treatment Market – By Treatment Type (Surgery, Radiation, Chemotherapy, Targeted Therapy, Immunotherapy), Stages of Disease (Stage I & II, Stage III, Stage IV), End-use (Hospitals, Specialty Clinics) – Global Forecast, 2024 – 2032

Report ID: GMI11125
Selected License: $8,350
Discount: $2,505
Order Total: $5,845

Need assistance?

Call us or write to us:

What You Get?

Billing Information

Payment Method


creditCardImage
Top